Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks.
Biosaf Health
; 4(4): 280-282, 2022 Aug.
Article
in English
| MEDLINE | ID: covidwho-2000280
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the practice of infectious diseases biobanking, as well as existing challenges and opportunities. Thus, the future of infectious diseases biobanking in the post-pandemic era, shall not be an "entry-level version" of its counterpart in non-communicable diseases and large population cohorts, but incorporate the lessons learned. Biobanks constitute a critical research infrastructure supported by harmonized practices through the implementation of international standards, and perceived within the broader scope of healthcare's intersection with research. This perspective paper considers the barriers in biobanking and standardization of practices, as well as the emerging opportunities in the field.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Language:
English
Journal:
Biosaf Health
Year:
2022
Document Type:
Article
Affiliation country:
J.bsheal.2022.06.003
Similar
MEDLINE
...
LILACS
LIS